LEXINGTON, S.C., April 23, 2025 /PRNewswire/ — Highlights for First Quarter 2025 Net income of $3.997 million. Diluted EPS of $0.51 per common share. Total deposits were $1.726 billion and customer deposits (excluding brokered CDs) were $1.715 billion at March 31, 2025. Customer deposit growth was $49.8 million during the quarter, a 12.1% annualized growth
HOUSTON and TUPELO, Miss., April 21, 2025 /PRNewswire/ — Cadence Bank (NYSE: CADE) (the Company), today announced financial results for the quarter ended March 31, 2025. Highlights for the first quarter of 2025 included: Reported quarterly net income available to common shareholders of $130.9 million, or $0.70 per diluted common share, and adjusted net income
MELVILLE, N.Y., March 31, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a leading provider of multi-cloud hosting, managed cloud services, disaster recovery, cybersecurity, and IT automation, with direct connection to AWS, Microsoft Azure, and Google Cloud, today provided a business update and reported financial results for the year ended
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company“) 2024 Full Year Financial Results 2024 – a pivotal year marking the transition from developer to producer at our flagship Nalunaq mine TORONTO, ONTARIO – 28 March 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining company with a substantial
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year. Operating loss for continuing operations was $0.1 million, compared to 11.7
GRAPEVINE, Texas, March 25, 2025 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today released financial results for the fourth quarter and fiscal year ended February 1, 2025. The Company’s consolidated financial statements, including GAAP and non-GAAP results, are below. The Company’s Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 First patient enrolled in Phase 2 FALCON trial of TERN-601 for obesity with 12-week data expected 4Q25 Cash, cash equivalents and marketable securities of $358 million, expected to
PRESS RELEASE Paris, 20 March 2025 – 5:45 pm YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION RESULTS 2024 Growth in turnover and operating profitability Turnover1 of €165.0m, up +€7.9m Increase of the operating EBITDA2 to €59.0m (+€3.6m) Group share of net profit: €3.9m (+€0.3m) Book value per share: €11.63 (+6%) Dividend increase to €0.15 per share
Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to achieve in vivo proof-of-concept in multiple secreted protein deficiencies to support wholly-owned follow-on program Progressed four Wave 1 Ionis targets to
HOUSTON, March 13, 2025 (GLOBE NEWSWIRE) — U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing assets, today reported financial and operating results for the fourth quarter and year ended December 31, 2024. FULL YEAR 2024 HIGHLIGHTS Continued the divestment of legacy